< Back to previous page
Researcher
Rob Lavigne
- Disciplines:Animal biology, Biological system engineering, Signal processing, Agricultural animal production
Affiliations
- Animal and Human Health Engineering (A2H) (Division)
Responsible
From1 Aug 2023 → Today - Animal and Human Health Engineering (A2H) (Division)
Member
From1 Aug 2020 → Today - Division Animal and Human Health Engineering (Division)
Member
From1 Aug 2015 → 31 Jul 2020 - Department of Biosystems (BIOSYST) (Department)
Member
From1 Aug 2006 → 30 Sep 2006
Projects
1 - 10 of 80
- Exploring the antibacterial and biotechnological potential of bacteriophagesFrom17 Jan 2024 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- RePhactor - Phage-based biosynthetic gene cluster refactoring for the discovery and yield improvement of novel bioactive natural productsFrom1 Jan 2024 → TodayFunding: FWO research project (including WEAVE projects)
- Bacteriophage research for biocontrol of Pseudomonas in cherryFrom10 Nov 2023 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Machine learning for small peptide discovery and function annotationFrom1 Nov 2023 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- An integrated approach to combat Staphylococcus aureus biofilms using designer enzymesFrom1 Oct 2023 → TodayFunding: IOF - technology validation in lab
- Direct deposition of therapeutic bacteriophages on orthopedic implant materials: development of an in vitro, preclinical proof-of-concept antibacterial strategy (PHAGE-DEPOSIT)From1 Oct 2023 → TodayFunding: BOF - projects
- SynBioS: Synergistic biocontrol technologies for disease and pest management in strawberryFrom1 Oct 2023 → TodayFunding: FWO Strategic Basic Research (SBO)
- Combining root-associated microorganisms and bacteriophages for enhanced biological control of pest insects.From19 Sep 2023 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- KLEOPATRA: Development and implementation of an effective combination of phages and antibiotics as an improved therapy against Klebsiella pneumoniaeFrom1 Jun 2023 → TodayFunding: FWO Strategic Basic Research (SBO)
- SynPhage (Synthetic Phage)From16 Jan 2023 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
Publications
1 - 10 of 346
- Endolysin NC5 improves early cloxacillin treatment in a mouse model of Streptococcus uberis mastitis.(2024)
Authors: Rob Lavigne
Pages: 118 - Complete genome sequences of two Leuconostoc carnosum strains: 4010 and AMS1(2024)
Authors: Cédric Lood, Rob Lavigne
- Phage proteins target and co-opt host ribosomes immediately upon infection.(2024)
Authors: Laura Wicke, Rob Lavigne
Pages: 787 - 800 - Meeting Report of the Second Symposium of the Belgian Society for Viruses of Microbes and Launch of the Phage Valley(2024)
Authors: Rob Lavigne, Jelle Matthijnssens, Jeroen Wagemans
- Exploiting phage-antibiotic synergies to disrupt Pseudomonas aeruginosa PAO1 biofilms in the context of orthopedic infections(2024)
Authors: Jeroen Wagemans, Rob Lavigne, Annabel Braem
- Tail-tape-fused virion and non-virion RNA polymerases of a thermophilic virus with an extremely long tail(2024)
Authors: Maarten Boon, Rob Lavigne
- FLAMS: Find Lysine Acylations and other Modification Sites(2024)
Authors: Hannelore Longin, Nand Broeckaert, Maarten Langen, Hanne Hendrix, Rob Lavigne, Vera van Noort
- Refining the transcriptional landscapes for distinct clades of virulent phages infecting Pseudomonas aeruginosa.(2024)
Authors: Maarten Boon, Vera van Noort, Rob Lavigne
Pages: uqae002 - Impact of phage predation on P. aeruginosa adhered to human airway epithelium: major transcriptomic changes in metabolism and virulence-associated genes(2023)
Authors: Leena Putzeys, Jan Paeshuyse, Rob Lavigne
Pages: 235 - 247 - The phage-encoded PIT4 protein affects multiple two-component systems of Pseudomonas aeruginosa(2023)
Authors: Kaat Schroven, Leena Putzeys, Jan Paeshuyse, Rob Lavigne
Patents
1 - 10 of 10
- Antimicrobial agents (Inventor)
- Antimicrobial agents (Inventor)
- Novel dnase (Inventor)
- New endolysin obpgplys (Inventor)
- Polynucleotide shuffling method (Inventor)
- Novel dnase (Inventor)
- Antimicrobial agents (Inventor)
- Polynucleotide shuffling method (Inventor)
- Antimicrobial agents (Inventor)
- Antimicrobial agents (Inventor)